SG10201912572VA - Treatment of diabetic peripheral neuropathy using placental cells - Google Patents
Treatment of diabetic peripheral neuropathy using placental cellsInfo
- Publication number
- SG10201912572VA SG10201912572VA SG10201912572VA SG10201912572VA SG10201912572VA SG 10201912572V A SG10201912572V A SG 10201912572VA SG 10201912572V A SG10201912572V A SG 10201912572VA SG 10201912572V A SG10201912572V A SG 10201912572VA SG 10201912572V A SG10201912572V A SG 10201912572VA
- Authority
- SG
- Singapore
- Prior art keywords
- treatment
- peripheral neuropathy
- placental cells
- diabetic peripheral
- diabetic
- Prior art date
Links
- 208000032131 Diabetic Neuropathies Diseases 0.000 title 1
- 230000003169 placental effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/48—Reproductive organs
- A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Developmental Biology & Embryology (AREA)
- Cell Biology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Reproductive Health (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Pregnancy & Childbirth (AREA)
- Dermatology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562218885P | 2015-09-15 | 2015-09-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG10201912572VA true SG10201912572VA (en) | 2020-02-27 |
Family
ID=58289824
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10201912572VA SG10201912572VA (en) | 2015-09-15 | 2016-09-14 | Treatment of diabetic peripheral neuropathy using placental cells |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US20180264048A1 (en) |
| EP (2) | EP3349771A4 (en) |
| JP (3) | JP2018529683A (en) |
| KR (1) | KR20180051631A (en) |
| CN (1) | CN108367028A (en) |
| AU (1) | AU2016323120A1 (en) |
| BR (1) | BR112018005014B1 (en) |
| CA (1) | CA2998759A1 (en) |
| CO (1) | CO2018003759A2 (en) |
| EA (1) | EA201890720A1 (en) |
| IL (2) | IL281185B2 (en) |
| MX (1) | MX2018003275A (en) |
| NZ (1) | NZ740663A (en) |
| SG (1) | SG10201912572VA (en) |
| WO (1) | WO2017048741A1 (en) |
| ZA (1) | ZA201801708B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20240058180A (en) | 2021-11-10 | 2024-05-03 | 미쯔비시 케미컬 주식회사 | Carbon fiber, carbon fiber bundle and method of manufacturing carbon fiber bundle |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5190556A (en) | 1991-03-19 | 1993-03-02 | O.B. Tech, Inc. | Cord cutter sampler |
| US5372581A (en) | 1993-07-21 | 1994-12-13 | Minneapolis Children's Services Corporation | Method and apparatus for placental blood collection |
| DE60034045T2 (en) | 1999-04-16 | 2007-11-22 | WM. Marsh Rice University, Houston | Biodegradable polypropylene fumarate networks crosslinked with polypropylene fumarate diacrylate macromers |
| US6355699B1 (en) | 1999-06-30 | 2002-03-12 | Ethicon, Inc. | Process for manufacturing biomedical foams |
| US7311905B2 (en) | 2002-02-13 | 2007-12-25 | Anthrogenesis Corporation | Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells |
| EP1349918B1 (en) | 2000-12-06 | 2014-08-06 | Anthrogenesis Corporation | Method of collecting placental stem cells |
| ES2444548T3 (en) | 2001-02-14 | 2014-02-25 | Anthrogenesis Corporation | Renovation and repopulation of cadaveric tissues and organs decellularized by stem cells |
| WO2002064755A2 (en) | 2001-02-14 | 2002-08-22 | Anthrogenesis Corporation | Post-partum mammalian placenta, its use and placental stem cells therefrom |
| US20030187515A1 (en) | 2002-03-26 | 2003-10-02 | Hariri Robert J. | Collagen biofabric and methods of preparing and using the collagen biofabric |
| US20040161419A1 (en) * | 2002-04-19 | 2004-08-19 | Strom Stephen C. | Placental stem cells and uses thereof |
| US7255729B2 (en) | 2003-05-30 | 2007-08-14 | Noritake Co., Limited | Porous cylindrical-body module, structure for supporting porous cylindrical bodies, and method for fastening a supporting member |
| US7147626B2 (en) | 2004-09-23 | 2006-12-12 | Celgene Corporation | Cord blood and placenta collection kit |
| CN103060263B (en) | 2005-12-29 | 2016-03-16 | 人类起源公司 | Placental stem cell populations |
| US9598669B2 (en) | 2005-12-29 | 2017-03-21 | Anthrogenesis Corporation | Composition for collecting placental stem cells and methods of using the composition |
| PL2556145T3 (en) * | 2010-04-07 | 2017-02-28 | Anthrogenesis Corporation | Angiogenesis using placental stem cells |
| MX357749B (en) * | 2011-06-01 | 2018-07-23 | Anthrogenesis Corp | Treatment of pain using placental stem cells. |
-
2016
- 2016-09-14 CN CN201680063078.5A patent/CN108367028A/en active Pending
- 2016-09-14 WO PCT/US2016/051571 patent/WO2017048741A1/en active Application Filing
- 2016-09-14 CA CA2998759A patent/CA2998759A1/en active Pending
- 2016-09-14 EP EP16847157.1A patent/EP3349771A4/en not_active Withdrawn
- 2016-09-14 KR KR1020187010423A patent/KR20180051631A/en not_active Application Discontinuation
- 2016-09-14 AU AU2016323120A patent/AU2016323120A1/en not_active Abandoned
- 2016-09-14 JP JP2018513527A patent/JP2018529683A/en active Pending
- 2016-09-14 IL IL281185A patent/IL281185B2/en unknown
- 2016-09-14 US US15/759,828 patent/US20180264048A1/en not_active Abandoned
- 2016-09-14 NZ NZ740663A patent/NZ740663A/en unknown
- 2016-09-14 EA EA201890720A patent/EA201890720A1/en unknown
- 2016-09-14 SG SG10201912572VA patent/SG10201912572VA/en unknown
- 2016-09-14 MX MX2018003275A patent/MX2018003275A/en unknown
- 2016-09-14 BR BR112018005014-8A patent/BR112018005014B1/en active IP Right Grant
- 2016-09-14 EP EP21186345.1A patent/EP3957315A1/en active Pending
-
2018
- 2018-03-12 IL IL258048A patent/IL258048A/en unknown
- 2018-03-13 ZA ZA2018/01708A patent/ZA201801708B/en unknown
- 2018-04-09 CO CONC2018/0003759A patent/CO2018003759A2/en unknown
-
2021
- 2021-08-19 JP JP2021133914A patent/JP2021183635A/en active Pending
- 2021-11-17 US US17/455,322 patent/US20220072063A1/en active Pending
-
2023
- 2023-09-08 JP JP2023145722A patent/JP2023171769A/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP3957315A1 (en) | 2022-02-23 |
| AU2016323120A1 (en) | 2018-04-12 |
| CA2998759A1 (en) | 2017-03-23 |
| JP2023171769A (en) | 2023-12-05 |
| US20220072063A1 (en) | 2022-03-10 |
| CN108367028A (en) | 2018-08-03 |
| EP3349771A1 (en) | 2018-07-25 |
| JP2021183635A (en) | 2021-12-02 |
| ZA201801708B (en) | 2019-01-30 |
| BR112018005014A2 (en) | 2018-10-02 |
| IL281185A (en) | 2021-04-29 |
| NZ740663A (en) | 2022-12-23 |
| IL281185B1 (en) | 2024-01-01 |
| MX2018003275A (en) | 2018-05-16 |
| IL258048A (en) | 2018-05-31 |
| EP3349771A4 (en) | 2019-04-24 |
| CO2018003759A2 (en) | 2018-12-14 |
| EA201890720A1 (en) | 2018-09-28 |
| JP2018529683A (en) | 2018-10-11 |
| US20180264048A1 (en) | 2018-09-20 |
| BR112018005014B1 (en) | 2022-03-22 |
| KR20180051631A (en) | 2018-05-16 |
| WO2017048741A1 (en) | 2017-03-23 |
| IL281185B2 (en) | 2024-05-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL283733A (en) | Methods of cancer treatment using activated t cells | |
| IL283258A (en) | Treatment of hypoparathyroidism | |
| EP3261713A4 (en) | Blood pump for treatment of bradycardia | |
| IL259486A (en) | Agents for the treatment of diseases associated with undesired cell proliferation | |
| HK1256042A1 (en) | Hdac inhibitors for the treatment of diabetic peripheral neuropathy | |
| EP3297653A4 (en) | Treatment of post-bariatric hypoglycemia with glp-1 antagonists | |
| HK1249866A1 (en) | Methods of treatment with taselisib | |
| GB201519450D0 (en) | Novel treatment | |
| HK1250329A1 (en) | Treatment of ocular conditions using progenitor cells | |
| GB201522223D0 (en) | Therapeutic T cells | |
| GB201519331D0 (en) | Treatment paradigm | |
| ZA201608406B (en) | Enzyme treatment composition | |
| IL281185A (en) | Treatment of diabetic peripheral neuropathy using placental cells | |
| EP3271017A4 (en) | Treatment of skin conditions | |
| EP3197467A4 (en) | Treatment of diabetic foot ulcer using placental stem cells | |
| GB201511752D0 (en) | Treatment of post-consumer bales | |
| IL267231A (en) | Methods of treating diseases associated with ilc2 cells | |
| IL262951A (en) | Methods of treating diseases associated with ilc3 cells | |
| EP2976078A4 (en) | Treatment of chemotherapy-induced peripheral neuropathy | |
| GB201517329D0 (en) | Diabetes gene therapy | |
| HK1245069A1 (en) | Improvements relating to retinal treatment | |
| ZA201608404B (en) | Enzyme treatment composition | |
| AU2015904246A0 (en) | Treatment of diabetes | |
| AU2015901496A0 (en) | Electrochemical Treatment Methods | |
| AU2015900943A0 (en) | Treatment of skin conditions |